Email this article 
An attempt to improve the results of treatment for breast cancer complicated by lysis
- Authors: Khakimov G.A.1, Madalimov A.K.1, Khakimova S.G.1, Dzhumaniyozov K.I.1
-
Affiliations:
- Tashkent City Oncology Dispensary, Uzbekistan Tashkent Pediatric Medical Institute, Uzbekistan
- Issue: No 3 (2014)
- Pages: 20-24
- Section: MAMMOLOGY. TREATMENT
- Published: 07.11.2014
- URL: https://ojrs.abvpress.ru/ojrs/article/view/388
- DOI: https://doi.org/10.17650/1994-4098-2014-0-3-20-24
- ID: 388
Cite item
Full Text
Abstract
Lysis in locally advanced breast cancer (BC) is not a sign of tumor process dissemination. The correct elaboration of management tactics for such patients may achieve rather good early and late results. The doxorubicin + xeloda regimen for BC complicated by lysis has some advantage over the FAC regimen, without additionally increasing the rate of adverse reactions and worsening the quality of life.
Keywords
About the authors
G. A. Khakimov
Tashkent City Oncology Dispensary, UzbekistanTashkent Pediatric Medical Institute, Uzbekistan
Author for correspondence.
Russian Federation
A. K. Madalimov
Tashkent City Oncology Dispensary, UzbekistanTashkent Pediatric Medical Institute, Uzbekistan
Russian Federation
Sh. G. Khakimova
Tashkent City Oncology Dispensary, UzbekistanTashkent Pediatric Medical Institute, Uzbekistan
Email: shahnoz_hakimova@mail.ru
Russian Federation
Kh. I. Dzhumaniyozov
Tashkent City Oncology Dispensary, UzbekistanTashkent Pediatric Medical Institute, Uzbekistan
Russian Federation
References
Supplementary files
